ONLINE LIBRARY

Articles and data focusing on covid ecmo and related issues

ECMO

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases (Published Online: 20 March 2020) 

Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease indications, timing, and implementation
(Published Online: 28 February 2020)

Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation
(Published Online: 19 February 2020)

Coronavirus epidemic: preparing for extracorporeal organ support in intensive care (Published Online: 6 February 2020)

recent epidemiological publications and summaries

John Hopkins University Corona Virus Resource Center

Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis (Published : April 2020)

Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation With Biocidal Agents (Published Online: March 2020)

Association of Radiologic Findings With Mortality of Patients Infected With 2019 Novel Coronavirus in Wuhan, China
(Published Online: 19 March 2020)

Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures (Published Online: 19 March 2020)

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19 (Published Online: 18 March 2020) 

COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics (Published Online: 18 March 2020)

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Published Online: 18 March 2020)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
(Published Online: 18 March 2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial
(Published Online: 18 March 2020)

Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
(Published Online: 18 March 2020)

SARS-CoV-2 Infection in Children (Published Online: 18 March 2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (Published Online: 17 March 2020)

Coronavirus in pregnancy and delivery: Rapid review (Published Online: 17 March 2020)

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China
(Published Online: 17 March 2020)

COVID-19: Consider cytokine storm syndromes and immunosuppression (Published Online: 16 March 2020)

COVID-19 – what should anaethesiologists and intensivists know about it? (Published Online: 16 March 2020)

2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics
(Published Online: 14 March 2020)

Coronavirus Disease 2019 (COVID‐19): What we know? (Published Online: 14 March 2020)

COVID-19, ECMO, and lymphopenia: A word of caution (Published Online: 13 March 2020)

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China (Published Online: 13 March 2020)

The convalescent sera option for containing COVID-19 (Published Online: 13 March 2020)

Teicoplanin: An Alternative Drug for the Treatment of Coronavirus COVID-19? (Published Online: 13 March 2020)

COVID-19 induced Renin–Angiotensin System (RAS) imbalance may drive acute lung injury: The evidence and therapeutic options
(Published Online: 12 March 2020)

Arbidol Combined With LPV/r Versus LPV/r Alone Against Corona Virus Disease 2019: A Retrospective Cohort Study
(Published Online: 11 March 2020)

How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People’s Hospital
(Published Online: 11 March 2020)

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential (Published Online: 10 March 2020)

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis (Published Online: 10 March 2020)

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
(Published Online: 9 March 2020)

Timely development of vaccines against SARS-CoV-2 (Published Online: 8 March 2020)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections (Published Online: 6 March 2020)

SARS-CoV-2: A potential novel etiology of fulminant myocarditis (Published Online: 5 March 2020)

Guidelines for pregnant women with suspected SARS-CoV-2 infection (Published Online: 3 March 2020)

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV
(Published Online: February 2020)

A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS coronavirus – A Possible Reference for Coronavirus disease-19 Treatment Option (Published Online: 27 February 2020)

COVID-19: Combining antiviral and anti-inflammatory treatments (Published Online: 27 February 2020)

Positive RT-PCR Test Results in Patients Recovered From COVID-19 (Published Online: 27 February 2020)

Non-invasive respiratory support for patients with novel coronavirus pneumonia clinical efficacy and reduction in risk of infection transmission (Published Online: 24 February 2020)

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection (Published Online: 20 February 2020)

An interactive web-based dashboard to track COVID-19 in real time (Published Online: 19 February 2020)

Virus against virus: A potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses (Published Online: 18 February 2020)

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines (Published Online: 13 February 2020)

Therapeutic options for the 2019 novel coronavirus (2019-nCoV) (Published Online: 10 February 2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Published Online: 4 February 2020)

Potent Binding of 2019 Novel Coronavirus Spike Protein by a SARS Coronavirus-Specific Human Monoclonal Antibody
(Published Online: 27 January 2020)

Global research on coronavirus disease (COVID-19) and Database of publications on coronavirus disease (COVID-19)

Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population
(Published Online: 9 July 2008)

diagnosis

Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? (Published Online: 13 March 2020)

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. (Published Online: 12 March 2020)

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis (Published Online: 3 March 2020)

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. (Published Online: 19 February 2020)

pathophysiology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (Published Online: 19 March 2020)

Dysregulation of immune response in patients with COVID-19 in Wuhan, China. (Published Online: 12 March 2020)

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection (Published Online: 8  February 2020)

prevention

Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak –Lessons from Taiwan’s SARS response.
(Published Online: 12 March 2020)

pediatrics

SARS-CoV-2 Infection in Children. (Published Online: 18 March 2020)

Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. (Published Online: 12 March 2020)

pregnancy

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. (Published Online: 27 February 2020)

treatment strategies

Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? (Published Online: 13 March 2020)

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Published Online: 9 March 2020)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (Published Online: 5 March 2020)

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics (Published Online: 4 March 2020)

Remdesivir: A Promising Antiviral Against Coronaviruses (Published Online: 3 March 2020)

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19  (Published Online: 28 February 2020)

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. (Published Online: 6 February 2020)

Discovering drugs to treat coronavirus disease 2019 (COVID-19). (Published Online: 2020)

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)

cardiovascular flashlight

Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin.

The COVID19 related activities of the EuroELSO are supported with an unrestricted Educational Grant of Getinge.

In cooperation with Tereza Radl and CZECH HEALTH INTERACTIVE, s.r.o.

EuroElso